Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes
|
Apr 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence
|
Aug 2017
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
microRNAs in myelodysplastic syndromes: How much do we know and not know?
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
|
Nov 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
|
Aug 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|